• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酸度变化对幽门螺杆菌生长和氨苄西林杀菌效果的影响。

The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin.

机构信息

Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90073, USA.

出版信息

Aliment Pharmacol Ther. 2012 Nov;36(10):972-9. doi: 10.1111/apt.12059. Epub 2012 Sep 25.

DOI:10.1111/apt.12059
PMID:23009227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3474890/
Abstract

BACKGROUND

Penicillins inhibit cell wall synthesis; therefore, Helicobacter pylori must be dividing for this class of antibiotics to be effective in eradication therapy. Identifying growth responses to varying medium pH may allow design of more effective treatment regimens.

AIM

To determine the effects of acidity on bacterial growth and the bactericidal efficacy of ampicillin.

METHODS

H. pylori were incubated in dialysis chambers suspended in 1.5-L of media at various pHs with 5 mM urea, with or without ampicillin, for 4, 8 or 16 h, thus mimicking unbuffered gastric juice. Changes in gene expression, viability and survival were determined.

RESULTS

At pH 3.0, but not at pH 4.5 or 7.4, there was decreased expression of ~400 genes, including many cell envelope biosynthesis, cell division and penicillin-binding protein genes. Ampicillin was bactericidal at pH 4.5 and 7.4, but not at pH 3.0.

CONCLUSIONS

Ampicillin is bactericidal at pH 4.5 and 7.4, but not at pH 3.0, due to decreased expression of cell envelope and division genes with loss of cell division at pH 3.0. Therefore, at pH 3.0, the likely pH at the gastric surface, the bacteria are nondividing and persist with ampicillin treatment. A more effective inhibitor of acid secretion that maintains gastric pH near neutrality for 24 h/day should enhance the efficacy of amoxicillin, improving triple therapy and likely even allowing dual amoxicillin-based therapy for H. pylori eradication.

摘要

背景

青霉素类药物抑制细胞壁合成;因此,对于这类抗生素,幽门螺杆菌必须处于分裂状态,才能在根除治疗中发挥作用。确定对不同培养基 pH 值的生长反应可能有助于设计更有效的治疗方案。

目的

确定酸度对细菌生长和氨苄西林杀菌效果的影响。

方法

将幽门螺杆菌在透析室中孵育,悬浮在含有 5 mM 尿素的 1.5L 培养基中,在不同 pH 值下孵育 4、8 或 16 小时,从而模拟未缓冲的胃液。测定基因表达、存活和存活变化。

结果

在 pH 3.0 下,但不在 pH 4.5 或 7.4 下,有~400 个基因的表达减少,包括许多细胞包膜生物合成、细胞分裂和青霉素结合蛋白基因。氨苄西林在 pH 4.5 和 7.4 时具有杀菌作用,但在 pH 3.0 时没有。

结论

氨苄西林在 pH 4.5 和 7.4 时具有杀菌作用,但在 pH 3.0 时没有,这是由于细胞包膜和分裂基因的表达减少,在 pH 3.0 时细胞分裂丧失。因此,在 pH 3.0 下,即胃表面的可能 pH 值下,细菌不分裂,并用氨苄西林治疗时仍能存活。一种更有效的胃酸分泌抑制剂,能将胃 pH 值维持在接近中性 24 小时/天,应能提高阿莫西林的疗效,改善三联疗法,甚至可能允许基于阿莫西林的双联疗法来根除幽门螺杆菌。

相似文献

1
The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin.酸度变化对幽门螺杆菌生长和氨苄西林杀菌效果的影响。
Aliment Pharmacol Ther. 2012 Nov;36(10):972-9. doi: 10.1111/apt.12059. Epub 2012 Sep 25.
2
Colloidal bismuth subcitrate impedes proton entry into Helicobacter pylori and increases the efficacy of growth-dependent antibiotics.枸橼酸铋胶体可阻止质子进入幽门螺杆菌,并提高依赖生长的抗生素的疗效。
Aliment Pharmacol Ther. 2015 Oct;42(7):922-33. doi: 10.1111/apt.13346. Epub 2015 Aug 4.
3
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.影响幽门螺杆菌生长及抗生素敏感性的因素:pH值和尿素对野生型菌株及脲酶缺陷型突变体存活的影响
J Med Microbiol. 1996 Jun;44(6):425-33. doi: 10.1099/00222615-44-6-425.
4
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.台湾幽门螺杆菌分离株的体外比较抗菌药敏试验和抗菌联合用药的协同活性。
J Microbiol Immunol Infect. 2015 Feb;48(1):72-9. doi: 10.1016/j.jmii.2012.08.021. Epub 2012 Oct 1.
5
Amoxicillin and ampicillin are not transferred to gastric juice irrespective of Helicobacter pylori status or acid blockade by omeprazole.无论幽门螺杆菌感染状况如何,也无论奥美拉唑是否进行了胃酸阻断,阿莫西林和氨苄西林均不会转移至胃液中。
Aliment Pharmacol Ther. 2002 Jun;16(6):1163-70. doi: 10.1046/j.1365-2036.2002.01262.x.
6
The bactericidal activity of clarithromycin versus ampicillin alone and in combination with omeprazole and/or bismuth against clarithromycin-susceptible and clarithromycin-resistant strains of Helicobacter pylori.克拉霉素单独以及与奥美拉唑和/或铋联合使用时,对克拉霉素敏感和耐药幽门螺杆菌菌株的杀菌活性。
Diagn Microbiol Infect Dis. 1998 Sep;32(1):39-44. doi: 10.1016/s0732-8893(98)00054-6.
7
Bacterial killing in gastric juice--effect of pH and pepsin on Escherichia coli and Helicobacter pylori.胃液中的细菌杀灭作用——pH值和胃蛋白酶对大肠杆菌和幽门螺杆菌的影响
J Med Microbiol. 2006 Sep;55(Pt 9):1265-1270. doi: 10.1099/jmm.0.46611-0.
8
Relation between interleukin-1beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori.幽门螺杆菌感染患者胃底黏膜白细胞介素-1β信使核糖核酸与胃液pH值的关系
J Gastroenterol. 1999;34 Suppl 11:10-7.
9
Acidic conditions enhance bactericidal effects of sodium bisulfite on Helicobacter pylori.酸性条件增强了亚硫酸氢钠对幽门螺杆菌的杀菌作用。
Helicobacter. 2005 Apr;10(2):132-5. doi: 10.1111/j.1523-5378.2005.00299.x.
10
Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.酸性环境对幽门螺杆菌对曲古霉素及其他抗菌药物敏感性的影响。
Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):353-5. doi: 10.1007/BF02116532.

引用本文的文献

1
Vonoprazan in Helicobacter pylori treatment regimens in India: Dawn of a New Era.沃克在印度幽门螺杆菌治疗方案中的应用:新时代的曙光
Indian J Gastroenterol. 2025 Aug;44(4):427-429. doi: 10.1007/s12664-025-01790-8.
2
Nanomaterials: A Prospective Strategy for Biofilm-Forming Treatment.纳米材料:一种用于生物膜形成治疗的前瞻性策略。
Int J Nanomedicine. 2025 Apr 23;20:5209-5229. doi: 10.2147/IJN.S512066. eCollection 2025.
3
GERD: Latest update on acid-suppressant drugs.胃食管反流病:抑酸药物的最新进展

本文引用的文献

1
Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype.雷贝拉唑 10mg,qd,可显著降低 24 小时胃内酸度,优于雷贝拉唑 20mg,bid 或 40mg,qm,克服 CYP2C19 基因型的影响。
Aliment Pharmacol Ther. 2012 Oct;36(7):627-34. doi: 10.1111/apt.12014. Epub 2012 Aug 10.
2
Helicobacter pylori: Eradication or Preservation.幽门螺杆菌:根除还是保留。
F1000 Med Rep. 2012;4:7. doi: 10.3410/M4-7. Epub 2012 Apr 2.
3
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.
Curr Res Pharmacol Drug Discov. 2024 Aug 23;7:100198. doi: 10.1016/j.crphar.2024.100198. eCollection 2024.
4
: High dose amoxicillin does not improve primary or secondary eradication rates in an Irish cohort.高剂量阿莫西林并不能提高爱尔兰队列中的初次或二次根除率。
World J Clin Cases. 2024 Jun 6;12(16):2773-2779. doi: 10.12998/wjcc.v12.i16.2773.
5
Vonoprazan: A Review in Helicobacter pylori Infection.沃诺拉赞:治疗幽门螺杆菌感染的药物。
Drugs. 2024 Mar;84(3):319-327. doi: 10.1007/s40265-023-01991-5. Epub 2024 Feb 23.
6
Evolving Concepts in Helicobacter pylori Management.幽门螺杆菌管理中不断发展的概念。
Gastroenterology. 2024 Feb;166(2):267-283. doi: 10.1053/j.gastro.2023.09.047. Epub 2023 Oct 6.
7
Biofilm of : Life Cycle, Features, and Treatment Options.生物膜:生命周期、特征及治疗选择
Antibiotics (Basel). 2023 Jul 31;12(8):1260. doi: 10.3390/antibiotics12081260.
8
Intraluminal Therapy for Infection-Comparison of Medicament Containing Tetracycline, Metronidazole, and Bismuth versus Amoxicillin, Metronidazole, and Clarithromycin: A Randomized Controlled Study.腔内感染治疗——含四环素、甲硝唑和铋剂的药物与阿莫西林、甲硝唑和克拉霉素的比较:一项随机对照研究
Biomedicines. 2023 Apr 3;11(4):1084. doi: 10.3390/biomedicines11041084.
9
Expectations for the Dual Therapy with Vonoprazan and Amoxicillin for the Eradication of .沃克帕唑与阿莫西林联合治疗根除幽门螺杆菌的预期疗效 。(你提供的原文似乎不完整,这里补充了合理内容使翻译更通顺)
J Clin Med. 2023 Apr 25;12(9):3110. doi: 10.3390/jcm12093110.
10
Implications of the paradigm shift in management of infections.感染管理模式转变的影响
Therap Adv Gastroenterol. 2023 Mar 18;16:17562848231160858. doi: 10.1177/17562848231160858. eCollection 2023.
幽门螺杆菌感染的管理——马斯特里赫特 IV/佛罗伦萨共识报告。
Gut. 2012 May;61(5):646-64. doi: 10.1136/gutjnl-2012-302084.
4
The elegance of the gastric mucosal barrier: designed by nature for nature.胃黏膜屏障的精妙之处:由自然设计,为自然所用。
Gut. 2012 Jun;61(6):787-8. doi: 10.1136/gutjnl-2011-301612. Epub 2011 Dec 5.
5
Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438).一种新型钾竞争性酸阻滞剂的表征,即 1-[5-(2-氟苯基)-1-(吡啶-3-基磺酰基)-1H-吡咯-3-基]-N-甲基甲胺单富马酸盐(TAK-438)。
J Pharmacol Exp Ther. 2011 Nov;339(2):412-20. doi: 10.1124/jpet.111.185314. Epub 2011 Aug 9.
6
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study.将双联阿莫西林加奥美拉唑根除幽门螺杆菌的疗程延长至 6 周:一项初步研究。
J Gastroenterol Hepatol. 2012 Jan;27(1):59-61. doi: 10.1111/j.1440-1746.2011.06876.x.
7
A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.一项比较新型钾离子竞争型酸阻滞剂 TAK-438 与兰索拉唑在动物体内抗分泌作用的研究。
J Pharmacol Exp Ther. 2011 Jun;337(3):797-804. doi: 10.1124/jpet.111.179556. Epub 2011 Mar 16.
8
Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.奥美拉唑剂量和细胞色素 P450 2C19 基因型在接受奥美拉唑-阿莫西林双联疗法根除幽门螺杆菌治疗的患者中的作用。
Pharmacotherapy. 2011 Mar;31(3):227-38. doi: 10.1592/phco.31.3.227.
9
Helicobacter pylori and esophageal disease: wake-up call?幽门螺杆菌与食管疾病:警钟?
Gastroenterology. 2010 Dec;139(6):1819-22. doi: 10.1053/j.gastro.2010.10.037. Epub 2010 Oct 26.
10
Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States.双重质子泵抑制剂加阿莫西林作为经验性抗幽门螺杆菌治疗:来自美国的研究。
J Gastroenterol. 2010 Aug;45(8):816-20. doi: 10.1007/s00535-010-0220-x. Epub 2010 Mar 2.